MEDICINES CO /DE company info

CIK 1113481
IRS Number 043324394
State of incorporation DE
Business address 8 SYLVAN WAY
None
PARSIPPANY
NJ
07054
Mail address 8 SYLVAN WAY
None
PARSIPPANY
NJ
07054

Short summary

MEDICINES CO /DE is a New Jersey company, with head office located at 8 Sylvan Way Parsippany, New Jersey 07054. In 2017 the company owned a total of 1.01 billion USD worth of assets, including 297.84 million USD worth of current assets. 2014 was the year when the company amassed the most assets.

MEDICINES CO /DE Income Statement

Name [in Millions USD]20072008200920102011201220132014201520162017Trends
Revenue, Net 348.16404.24437.65484.73558.59624.61659.69309.01167.84
Cost of Goods and Services Sold 88.36118.15129.30156.87177.34262.79233.33119.9371.35
Selling, General and Administrative Expense 164.90193.83158.69159.62171.75264.96314.95337.94319.15
Research and development 105.72117.6185.24110.18126.42138.26139.51123.61139.26
Operating Income (Loss) -10.82-25.3564.4258.0783.0713.19-28.11-272.47-361.93
Interest expense 008.0115.5315.7037.0944.46
Other Nonoperating Income (Expense) -2.82-0.271.791.141.580.920.400.33
Income Tax Expense (Benefit) 2.9248.06-40.49-50.0335.041.36-2.31-29.740.07
Net income -8.50-76.23104.64127.8851.1715.26-32.21-352.76-119.12

MEDICINES CO /DE Balance Sheet

Name [in Millions USD]20072008200920102011201220132014201520162017Trends
Cash and cash equivalents 88.1371.15101.70195.61452.34292.89368.27462.74644.20202.42166.73
Available-for-sale Securities, Current 117.118856.9050.90
Accounts Receivable, Net, Current 20.7267.0165.6690.33120.1252.6248.4115.577.79
Inventories 28.4229.1647.2086.7586.31127.7874.1271.4267.17
Deferred income taxes 09.4013.8813.4300
Property, Plant and Equipment, Gross 35.6735.4234.4160.7164.5863.1363.35
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -15.01-17.44-18.3121.4426.8428.3532.39
Goodwill 14.6714.6714.67135.63284.82313.51255.63255.63255.63
Available-for-sale Securities, Noncurrent 5.108.20
Intangible Assets, Net (Excluding Goodwill) 81.74121.84462.49900.731,039.16628.16289.07285.97
Other Assets, Noncurrent 0.260.3014.7517.5615.0213.500.740.750.78
Total assets 403.18538.68897.871,149.921,847.112,066.631,852.441,151.111,006.98
Current assets 275.23389.60652.45502.64603.09660.45789.33436.03297.84
Accounts payable 7.9517.277.115.078.2617.7026.7216.5311.70
Total current liabilities 80.13103.84116.37120.62179.09208.70220.11515.29128.91
Deferred income taxes 19.25034.50149.25163.9588.3967.000
Total liabilities 130.31137.11365.28492.49936.851,094.841,021.53946.10818.93
Common Stock, Value, Issued 0.050.050.060.060.070.070.070.080.08
Retained Earnings (Accumulated Deficit) -319.32-203.86-90.34-53.89-55.05-118.67-339.87-1,048.92-1,079.10
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.140.31-1.21-1.68-3.874.48-5.41-5.45-4.95

MEDICINES CO /DE Cash Flow

Name [in Millions USD]20072008200920102011201220132014201520162017Trends
Net income -8.50-76.23104.64127.8851.1715.26-32.21-352.76-119.12
Depreciation and amortization 2.935.776.12
Depreciation 4.604.403.602.903.905.604.703.70
Amortization of Intangible Assets 1.802.604.4028.5032.201725.80
Depreciation and amortization 5.776.126.237.2732.2434.4034.8431.04
Deferred Income Tax Expense (Benefit) 1.5247.74-43.59-53.2530.38-10.27-5.57-53.29-0.02
Accounts receivable 7.61-3.1816.6328.0911.1215.0254.74-103.10-30.14
Inventories -6.89-2.77-0.7019.7931.1510.13-5.6369.3215.65
Accounts payable 3.32-7.850.17-2.2018.90-1.32-6.8716.36-7.40
Deferred revenue 9.59-8.52-0.620.131.693.855.268.391.57
Net Cash Provided by (Used in) Operating Activities 38.080.9567.4796.3846.3591.4267.31-197.97-323.31
Payments to Acquire Property, Plant, and Equipment 19.400.340.341.271.0113.577.292.562.18
Payments to Acquire Businesses, Net of Cash Acquired 23.5337.17000542.5858.9328.400
Payments to Acquire Intangible Assets 200736.68015112.6210
Net Cash Provided by (Used in) Investing Activities -50.25-11.22-18.4078.41-63.51-504.36-84.76-123.51422.04
Proceeds from Issuance of Common Stock 5.541.803.366.7322.9474.2117.3495.2033.78
Payments for Repurchase of Common Stock 00500
Net Cash Provided by (Used in) Financing Activities 5.541.803.3616.12220.92271.498.83324.8370.58
Cash and Cash Equivalents, Period Increase (Decrease) -7.11-8.7954.14189.02204.06-142.72-5.992.43168.66